Insider Trading Activity Tivity Health (NASDAQ:TVTY) – CEO Sold 20,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Tivity Health (NASDAQ:TVTY)

Donato Tramuto , CEO of Tivity Health (NASDAQ:TVTY) reportedly Sold 20,000 shares of the company’s stock at an average price of 35.37 for a total transaction amount of $707,400.00 SEC Form

Insider Trading History For Tivity Health (NASDAQ:TVTY)

  • On 5/9/2013 John W Ballantine, Director, sold 27,400 with an average share price of $14.02 per share and the total transaction amounting to $384,148.00.
  • On 5/14/2013 Jay C Bisgard, Director, sold 18,343 with an average share price of $14.51 per share and the total transaction amounting to $266,156.93.
  • On 5/17/2013 Jay C Bisgard, Director, sold 2,039 with an average share price of $14.50 per share and the total transaction amounting to $29,565.50.
  • On 6/3/2013 Jay C Bisgard, Director, sold 4,869 with an average share price of $14.58 per share and the total transaction amounting to $70,990.02.
  • On 8/14/2013 Ben Leedle, Jr., CEO, sold 293,984 with an average share price of $18.68 per share and the total transaction amounting to $5,491,621.12.
  • On 8/14/2013 Alfred Lumsdaine, CFO, sold 9,425 with an average share price of $18.64 per share and the total transaction amounting to $175,682.00.
  • On 10/29/2013 Alfred Lumsdaine, CFO, bought 5,000 with an average share price of $10.80 per share and the total transaction amounting to $54,000.00.

    • Analyst Ratings History For Tivity Health (NASDAQ:TVTY)

    • On 8/10/2016 FBR & Co Boost Price Target of rating Outperform with a price target of $16.00 to $21.00
    • On 8/22/2016 Barclays Upgraded rating Underweight to Equal Weight with a price target of $12.00 to $27.00
    • On 6/23/2017 UBS Boost Price Target of rating Buy with a price target of $37.00 to $43.00
    • On 9/25/2017 Jefferies Group Reiterated Rating Buy with a price target of $46.00
    • On 10/27/2017 SunTrust Banks Set Price Target of rating Buy with a price target of $50.00
    • On 11/1/2017 Oppenheimer Boost Price Target of rating Outperform with a price target of $47.00 to $50.00
    • On 2/23/2018 Chardan Capital Reiterated Rating Neutral to Neutral with a price target of $44.00 to $41.00

    Recent Trading Activity for Tivity Health (NASDAQ:TVTY)
    Shares of Tivity Health closed the previous trading session at 35.72 down -0.08 0.21% with 35.900001525878906 shares trading hands.